日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Preclinical evaluation of a novel ATM inhibitor, KU59403, in vitro and in vivo in p53 functional and dysfunctional models of human cancer.

在人类癌症的 p53 功能和功能障碍模型中,对新型 ATM 抑制剂 KU59403 进行体外和体内临床前评估

Batey Michael A, Zhao Yan, Kyle Suzanne, Richardson Caroline, Slade Andrew, Martin Niall M B, Lau Alan, Newell David R, Curtin Nicola J

Vasoactivity of AG014699, a clinically active small molecule inhibitor of poly(ADP-ribose) polymerase: a contributory factor to chemopotentiation in vivo?

AG014699(一种临床上有效的聚(ADP-核糖)聚合酶小分子抑制剂)的血管活性:是体内化学增效的促成因素吗?

Ali Majid, Telfer Brian A, McCrudden Cian, O'Rourke Martin, Thomas Huw D, Kamjoo Marzieh, Kyle Suzanne, Robson Tracy, Shaw Chris, Hirst David G, Curtin Nicola J, Williams Kaye J